Share this to:

Support & Insight for the Autumn of Life

Future & Current Alzheimer’s Drugs


A plain-English look at dementia medications. Learn about current and future drugs. See what to expect in the years ahead from Biogen, Eli Lilly and other labs.


Notify of

1 Comment
Inline Feedbacks
View all comments
February 27, 2016 2:37 pm

We can find articles that proved that Solanezumab is a failed drug, searching in Google with the words "Solanezumab failure" .For example the scientific article published in the New England Journal of Medicine, 2014"title:
"Phase 3 Trials of Solanezumab for Mild l-to-Moderat Alzheimer's disease. "Authors: Doody and colleagues,from the Alzheimer's Disease and Memory Disorders Center, Department of Neurology, Baylor College of Medicine, Houston,U.S.A.,where we can read: " "Conclusion:Solanezumab, a humanized monoclonal antibody,that binds amyloid, FAILED to improves cognition or functional ability"

B. Berger

B. Berger

Visit Our Pages On:


This site was inspired by my Mom’s autoimmune dementia.

It is a place where we separate out the wheat from the chaffe, the important articles & videos from each week’s river of news. With a new post on Alzheimer’s or dementia appearing on the internet every 7 minutes, the site’s focus on the best information has been a help to many over the past 15 years. Thanks to our many subscribers for your supportive feedback.

The site is dedicated to all those preserving the dignity of the community of people living with dementia.

Peter Berger, Editor


Common Alzheimer's Medications Slow Cognitive Decline
Swedish researchers find that cholinesterase inhibitors provide cognitive benefits and reduce mortality for up to fiv...
Lilly's Donanemab: The 3rd New Alzheimer's Drug
Now, a third new Alzheimer's drug expected to be approved by the Food and Drug Administration (FDA),. The field of ne...
Leqembi Medication for Alzheimer's (Generic: Lecanemab)
Alzheimer's Drug Leqembi Gets Full FDA and MEDICARE Approval
First drug to modestly slow Alzheimer's cognitive decline, based on 1,800 patients.
Would love your thoughts, please comment.x
News, Treatments, Care Tips

Subscribe To The Weekly Newsletter

videos & articles on Research & Prevention
News to Get at the Truth

Subscribe To Our Weekly Newsletter